Presentation is loading. Please wait.

Presentation is loading. Please wait.

Prevalence and Significance of Unrecognized Renal Dysfunction in Patients with Stroke  David Pereg, MD, Zach Rozenbaum, MD, Dina Vorobeichik, MA, Nir Shlomo,

Published byYuliani Susanto Modified over 5 years ago

Similar presentations

Presentation on theme: "Prevalence and Significance of Unrecognized Renal Dysfunction in Patients with Stroke  David Pereg, MD, Zach Rozenbaum, MD, Dina Vorobeichik, MA, Nir Shlomo,"— Presentation transcript:

1 Prevalence and Significance of Unrecognized Renal Dysfunction in Patients with Stroke 
David Pereg, MD, Zach Rozenbaum, MD, Dina Vorobeichik, MA, Nir Shlomo, MA, Ronit Gilad, MD, Sivan Bloch, MD, Morris Mosseri, MD, David Tanne, MD  The American Journal of Medicine  Volume 129, Issue 10, Pages (October 2016) DOI: /j.amjmed Copyright © 2016 Elsevier Inc. Terms and Conditions

2 Figure 1 Subgroup analysis of the comparison of primary outcomes between patients with normal renal function and unrecognized renal dysfunction. (Using the group with unrecognized renal insufficiency as the reference group with OR = 1.) A, In-hospital mortality. B, In-hospital mortality or severe disability at discharge (modified Rankin scale >3). CI = confidence interval; ICH = intracerebral hemorrhage; mRS = modified Rankin scale; OR = odds ratio; TIA = transient ischemic attack. The American Journal of Medicine  , DOI: ( /j.amjmed ) Copyright © 2016 Elsevier Inc. Terms and Conditions

3 Figure 2 Subgroup analysis of the comparison of primary outcomes between patients with recognized and unrecognized renal dysfunction. (Using the group with unrecognized renal insufficiency as the reference group with OR = 1.) A, In-hospital mortality. B, In-hospital mortality or severe disability at discharge (modified Rankin scale >3). CI = confidence interval; ICH = intracerebral hemorrhage, mRS = modified Rankin scale; OR = odds ratio; TIA = transient ischemic attack. The American Journal of Medicine  , DOI: ( /j.amjmed ) Copyright © 2016 Elsevier Inc. Terms and Conditions

Download ppt "Prevalence and Significance of Unrecognized Renal Dysfunction in Patients with Stroke  David Pereg, MD, Zach Rozenbaum, MD, Dina Vorobeichik, MA, Nir Shlomo,"

Similar presentations

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.
An Unusual Electrocardiogram in a Heart Transplant Recipient Hamish I. MacLachlan, BSc, MBBS, Jonathan R. Dalzell, MD, MRCP The American Journal of Medicine.

An Unusual Electrocardiogram in a Heart Transplant Recipient Hamish I. MacLachlan, BSc, MBBS, Jonathan R. Dalzell, MD, MRCP The American Journal of Medicine.
High Positive End-Expiratory Pressure Is Associated with Improved Survival in Obese Patients with Acute Respiratory Distress Syndrome  Christian Bime,

High Positive End-Expiratory Pressure Is Associated with Improved Survival in Obese Patients with Acute Respiratory Distress Syndrome  Christian Bime,
Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO 

Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO 
The Effect of Smoking on the Risk of Sciatica: A Meta-analysis

The Effect of Smoking on the Risk of Sciatica: A Meta-analysis
Alfred A. Bartolucci, PhD, Michal Tendera, MD, George Howard, DrPH 

Alfred A. Bartolucci, PhD, Michal Tendera, MD, George Howard, DrPH 
An Unusual Cause of Leg Ulcerations

An Unusual Cause of Leg Ulcerations
Impact of More Restrictive Blood Transfusion Strategies on Clinical Outcomes: A Meta- analysis and Systematic Review  Shelley R. Salpeter, MD, Jacob S.

Impact of More Restrictive Blood Transfusion Strategies on Clinical Outcomes: A Meta- analysis and Systematic Review  Shelley R. Salpeter, MD, Jacob S.
Richard V. Milani, MD, Carl J. Lavie, MD, Robert M

Richard V. Milani, MD, Carl J. Lavie, MD, Robert M
Alexander A. Leung, MD, MPH, Finlay A. McAlister, MD, MSc, Samuel R. G

Alexander A. Leung, MD, MPH, Finlay A. McAlister, MD, MSc, Samuel R. G
Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease  Sripal Bangalore, MD, MHA, Rana Fayyad, PhD,

Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease  Sripal Bangalore, MD, MHA, Rana Fayyad, PhD,
Early Invasive Versus Initial Conservative Strategies for Women with Non–ST-Elevation Acute Coronary Syndromes: A Nationwide Analysis  Islam Y. Elgendy,

Early Invasive Versus Initial Conservative Strategies for Women with Non–ST-Elevation Acute Coronary Syndromes: A Nationwide Analysis  Islam Y. Elgendy,
Trends in Comorbidity, Disability, and Polypharmacy in Heart Failure

Trends in Comorbidity, Disability, and Polypharmacy in Heart Failure
Bertha Wong, MD, Muhammad M. Mamdani, PharmD, MPH, Catherine H

Bertha Wong, MD, Muhammad M. Mamdani, PharmD, MPH, Catherine H
Phosphorus and Risk of Renal Failure in Subjects with Normal Renal Function  John J. Sim, MD, Simran K. Bhandari, MD, Ning Smith, PhD, Joanie Chung, MS,

Phosphorus and Risk of Renal Failure in Subjects with Normal Renal Function  John J. Sim, MD, Simran K. Bhandari, MD, Ning Smith, PhD, Joanie Chung, MS,
Impact of Hyponatremia Correction on the Risk for 30-Day Readmission and Death in Patients with Congestive Heart Failure  Jacques D. Donzé, MD, MSc, Patrick.

Impact of Hyponatremia Correction on the Risk for 30-Day Readmission and Death in Patients with Congestive Heart Failure  Jacques D. Donzé, MD, MSc, Patrick.
Trends in Stroke Rates, Risk, and Outcomes in the United States, 1988 to 2008  Margaret C. Fang, MD, MPH, Marcelo Coca Perraillon, MA, Kaushik Ghosh, PhD,

Trends in Stroke Rates, Risk, and Outcomes in the United States, 1988 to 2008  Margaret C. Fang, MD, MPH, Marcelo Coca Perraillon, MA, Kaushik Ghosh, PhD,
Venous Thromboembolism with Chronic Liver Disease

Venous Thromboembolism with Chronic Liver Disease
Overview of Current Learning Theories for Medical Educators

Overview of Current Learning Theories for Medical Educators
Schizophrenia for Primary Care Providers: How to Contribute to the Care of a Vulnerable Patient Population  Mark Viron, MD, Travis Baggett, MD, MPH, Michele.

Schizophrenia for Primary Care Providers: How to Contribute to the Care of a Vulnerable Patient Population  Mark Viron, MD, Travis Baggett, MD, MPH, Michele.

Similar presentations

Ads by Google